MBOAT2 is implicated in cancer, with upregulated expression in pancreatic cancer, invasive breast cancer, cholangiocarcinoma, and prostate adenocarcinoma [18,156]. This evidence concerns the gene MBOAT2 and pancreatic neoplasm.